Quaero Capital S.A. Zai Lab LTD Transaction History

Quaero Capital S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$54.9 - $105.21 $1.36 Million - $2.61 Million	-24,782 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$105.0 - $178.37 $452,970 - $769,488	4,314 Added 21.08%	24,782 $2.61 Million
Q2 2021 Jul 23, 2021	BUY	$125.11 - $180.0 $2.56 Million - $3.68 Million	20,468 New	20,468 $3.62 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Quaero Capital S.A., based on Form 13F filings with the SEC.

Stay updated on Quaero Capital S.A. with notifications on news.